Afternoon Market Losers

Synta Pharmaceuticals SNTA is down 32.32% to $4.99 after Synta reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of Ganetespib in second-line non-small cell lung cancer. Infinity Pharmaceuticals INFI dropped 26.10% to 19.92 on Phase 1 data. Affymax AFFY dropped 19.23% to $1.68 after this morning's delisting. Pandora P fell 12.10% to $14.96 after reports of a possible Apple AAPL iRadio reveal at WWDC.